Forecasts data is unavailable for this security.
Consensus recommendation
- 16-Nov-23
- 15-Aug-24
- 19-Sep-24
- 17-Oct-24
- 07-Nov-24
Select bar for recommendation details.
Recommendations | 07-Nov-24 | |
---|---|---|
Buy | 3 | |
Outperform | 8 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 11 analysts offering 12 month price targets for Avidity Biosciences Inc have a median target of 64.00, with a high estimate of 96.00 and a low estimate of 51.00. The median estimate represents a 36.99% increase from the last price of 46.72.
High | 105.5% | 96.00 |
Med | 37.0% | 64.00 |
Low | 9.2% | 51.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Feb 26, 2025.
Average growth rate | +1.61% |
Average growth rate | -14.45% |
More ▼
Revenue history & estimates in USD
Average growth rate | +2.83% |
Average growth rate | +13.32% |
More ▼